KIES PETER — SEC Form 4 filings
SEC reporting owner CIK 1259780. 9 Form 4 filings on record with FilingPulse; latest filed 2026-05-21.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-28 to 2026-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | CFO | 9 | — | — | 40 |
Form 4 filings — KIES PETER
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-21 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 8,700 · Tax withholding (F): 4,688 @ $1.23 · Option exercise (M): 8,700 (derivative) @ $0 · Grant/award (A): 39,760 (derivative) @ $0 · Grant/award (A): 32,480 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 4,771 · Tax withholding (F): 2,571 @ $1.30 · Option exercise (M): 4,771 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/award (A): 31,240 (derivative) @ $0 · Grant/award (A): 25,520 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 5,010 · Tax withholding (F): 2,965 @ $1.79 · Option exercise (M): 10,634 · Tax withholding (F): 6,294 @ $1.79 · Option exercise (M): 5,010 (derivative) @ $0 · Option exercise (M): 10,634 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/award (A): 26,100 (derivative) @ $0 · Grant/award (A): 31,950 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 4,771 · Tax withholding (F): 2,566 @ $1.95 · Option exercise (M): 4,771 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 3,997 · Tax withholding (F): 2,362 @ $1.98 · Option exercise (M): 5,010 · Tax withholding (F): 2,960 @ $1.98 · Option exercise (M): 3,997 (derivative) @ $0 · Option exercise (M): 5,010 (derivative) @ $0 · +2 more | EDGAR |
| 2024-05-16 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 4,771 · Tax withholding (F): 2,562 @ $13.07 · Option exercise (M): 4,771 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 1,878 · Tax withholding (F): 1,108 @ $8.16 · Option exercise (M): 3,997 · Tax withholding (F): 2,358 @ $8.16 · Option exercise (M): 1,878 (derivative) @ $0 · Option exercise (M): 3,997 (derivative) @ $0 · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1259780 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →